Publicaties
Neutrophils Kill Antibody-Opsonized Cancer Cells by Trogoptosis Vrije Universiteit Brussel
Destruction of cancer cells by therapeutic antibodies occurs, at least in part, through antibody-dependent cellular cytotoxicity (ADCC), and this can be mediated by various Fc-receptor-expressing immune cells, including neutrophils. However, the mechanism(s) by which neutrophils kill antibody-opsonized cancer cells has not been established. Here, we demonstrate that neutrophils can exert a mode of destruction of cancer cells, which involves ...
Extensions to the bupaR ecosystem: An overview Universiteit Hasselt
Mining Recency-Frequency-Monetary enriched insights into resources' collaboration behavior from event data Universiteit Hasselt
Assessment and treatment of muscle weakness in critically ill patients KU Leuven
Increased MUTYH mutation frequency among Dutch families with breast cancer and colorectal cancer Vrije Universiteit Brussel
Homozygous and compound heterozygous MUTYH mutations predispose for MUTYH-associated polyposis (MAP). The clinical phenotype of MAP is characterised by the multiple colorectal adenomas and colorectal carcinoma. We previously found that female MAP patients may also have an increased risk for breast cancer. Yet, the involvement of MUTYH mutations in families with both breast cancer and colorectal cancer is unclear. Here, we have genotyped the ...
Stigmatisering in psychiatrische ziekenhuizen: over de invloed van patiënt en organisationele context Universiteit Gent
Stigma-ervaringen in psychiatrische ziekenhuizen: maakt de zorgeenheid een verschil? Universiteit Gent
Combinations of single-top-quark production cross-section measurements and vertical bar f(LV)V(tb)vertical bar determinations at root s=7 and 8 TeV with the ATLAS and CMS experiments Universiteit Antwerpen Universiteit Gent Vrije Universiteit Brussel
The Design and Preclinical Evaluation of a Single-Label Bimodal Nanobody Tracer for Image-Guided Surgery Vrije Universiteit Brussel
Intraoperative guidance using targeted fluorescent tracers can potentially provide surgeons with real-time feedback on the presence of tumor tissue in resection margins. To overcome the limited depth penetration of fluorescent light, combining fluorescence with SPECT/CT imaging and/or gamma-ray tracing has been proposed. Here, we describe the design and preclinical validation of a novel bimodal nanobody-tracer, labeled using a ...